Cardinal Health logged a 4.1% change during today's evening session, and is now trading at a price of $212.79 per share.
Cardinal Health returned gains of 33.6% last year, with its stock price reaching a high of $233.6 and a low of $137.75. Over the same period, the stock outperformed the S&P 500 index by 10.9%. More recently, the company's 50-day average price was $202.02. Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. Based in Dublin, OH, the Large-Cap Health Care company has 53,084 full time employees. Cardinal Health has offered a 1.0% dividend yield over the last 12 months.
Growing Revenues but Not Enough Current Assets to Cover Current Liabilities:
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue (M) | $152,922 | $162,467 | $181,326 | $204,979 | $226,827 | $222,578 |
| Gross Margins | 4% | 4% | 4% | 3% | 3% | 4% |
| Net Margins | -2% | 0% | -1% | 0% | 0% | 1% |
| Net Income (M) | -$3,696 | $611 | -$938 | $330 | $852 | $1,561 |
| Net Interest Expense (M) | $238 | $180 | $147 | $84 | $51 | $215 |
| Depreciation & Amort. (M) | $405 | $377 | $412 | $441 | $470 | $488 |
| Diluted Shares (M) | 295 | 281 | 261 | 246 | 243 | 237 |
| Earnings Per Share | $4.04 | $2.08 | -$3.37 | $1.26 | $3.45 | $6.45 |
| EPS Growth | n/a | -48.51% | -262.02% | 137.39% | 173.81% | 86.96% |
| Avg. Price | $46.6 | $50.69 | $53.01 | $100.8 | $118.14 | $205.71 |
| P/E Ratio | 11.53 | 24.25 | -15.73 | 79.37 | 33.95 | 31.75 |
| Free Cash Flow (M) | $1,585 | $2,029 | $2,788 | $2,363 | $3,251 | $1,850 |
| CAPEX (M) | $375 | $400 | $387 | $481 | $511 | $547 |
| EV / EBITDA | -4.5 | 19.91 | -79.37 | 20.3 | 18.72 | 19.79 |
| Total Debt (M) | $6,720 | $5,342 | $4,685 | $3,535 | $7,062 | $8,347 |
| Net Debt / EBITDA | -0.81 | 2.57 | -5.29 | -0.89 | 1.9 | 2.02 |
| Current Ratio | 1.17 | 1.15 | 1.04 | 0.98 | 1.02 | 0.91 |
Cardinal Health has growing revenues and increasing reinvestment in the business and positive EPS growth. Additionally, the company's financial statements display generally positive cash flows and healthy leverage levels. However, the firm suffers from slimmer gross margins than its peers and not enough current assets to cover current liabilities because its current ratio is 0.91.
Cardinal Health's Valuation Is in Line With Its Sector Averages:
Cardinal Health has a trailing twelve month P/E ratio of 30.9, compared to an average of 22.94 for the Health Care sector. Based on its EPS guidance of $11.98, the company has a forward P/E ratio of 16.9. Cardinal Health's PEG ratio is 2.48 on the basis of the 12.5% weighted average of the company and the broader market's EPS compound average growth rates. This suggests that the company's shares are overvalued.
Cardinal Health Has an Average Rating of Buy:
The 15 analysts following Cardinal Health have set target prices ranging from $215.0 to $275.0 per share, for an average of $245.27 with a buy rating.
Cardinal Health has an average amount of shares sold short because 3.7% of the company's shares are sold short. Institutions own 89.9% of the company's shares, and the insider ownership rate stands at 0.26%, suggesting a small amount of insider investors. The largest shareholder is Blackrock Inc., whose 12% stake in the company is worth $6,063,411,742.
